Treatment Episode Data Set

Substance Abuse and Mental Health Services Administration Treatment episode data set (TEDS), 1999. Available at http //www.icpsr.umich.edu/cocoon/ICPSR STUDY/03314.xml. Accessed Feburary 13, 2004... 

Source SAMHSA (2000). Treatment Episode Data Set. Available at http //www.dasis.samhsa.gov/dasis2/index. htm... 

Hospital admissions due to benzodiazepine abuse have been studied as well. According to the Treatment Episode Data Set (TEDS) from the Substance Abuse and Mental Health Services Administration (SAMHSA) of the United States Department of Health and Human Services, tranquilizers such as the benzodiazepines were the primary substance of 0.3% of TEDS admissions in 1998. In addition, 39% of patients admitted for tranquilizer use reported abuse of alcohol as well as tranquilizers. Admissions for tranquilizer abuse were mostly female (48%) and white (90%). 

The Treatment Episode Data Set collects usage data from drug treatment centers around the country. Between 1993 and 1999, it was reported that metham-... 

Heroin abusers comprise the vast majority of those in treatment for opiate abuse. According to the SAMH-SA s Treatment Episode Data Set (TEDS), only 1% of admissions for addiction treatment recorded in 1999 were related to opiates other than heroin. However, the number of these admissions that was for opium itself cannot be determined from the available data because opium is categorized with all other drugs with morphinelike effects. Methadone was part of the treatment plan for 22% of those admitted. 

Treatment Episode Data Set (TEDS) 1994-1999. National Admissions to Substance Abuse Treatment Services. DASIS Series S-14, DHHS Publication No. (SMA) 01-3550. Rockville, MD Substance Abuse and Mental Health Services Administration (SAMHSA), 2001. . 

Treatment facilities have taken note that inhalant abusers most often do not solely abuse inhalants. In the 1999 Treatment Episode Data Set study by the Substance Abuse and Mental Health Services Administration (SAMHSA), 1,321 individuals were admitted for treatment of inhalant abuse. These cases, where inhalants were the primary abused drug, accounted for only 0.1% of admittances in the treatment facilities. Often patients reported inhalant use in addition to their primary substance of abuse. One-third of the inhalant users admitted that they began using inhalants by age 12, and an additional 24% began using inhalants between age 12 and 14. 

---